2,4-Dibromo-1,3-thiazole → 4-((4-Bromothiazol-2-yl)(5-ethoxy-2-fluoro-3-isopropoxyphenyl)methylamino)benzonitrile

HRID 2104957Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2104957
Br[C:2]1[S:3][CH:4]=[C:5]([Br:7])[N:6]=1.[Li]CCCC.[CH2:13]([O:15][C:16]1[CH:17]=[C:18]([O:33][CH:34]([CH3:36])[CH3:35])[C:19]([F:32])=[C:20]([CH:31]=1)/[CH:21]=[N:22]/[C:23]1[CH:30]=[CH:29][C:26]([C:27]#[N:28])=[CH:25][CH:24]=1)[CH3:14]>C1COCC1>[Br:7][C:5]1[N:6]=[C:2]([N:22]([CH2:21][C:20]2[CH:31]=[C:16]([O:15][CH2:13][CH3:14])[CH:17]=[C:18]([O:33][CH:34]([CH3:36])[CH3:35])[C:19]=2[F:32])[C:23]2[CH:30]=[CH:29][C:26]([C:27]#[N:28])=[CH:25][CH:24]=2)[S:3][CH:4]=1

Komponenten

5

Reaktionsbedingungen

Temperatur
-78 °C

Versuchsvorschrift

To a solution of 2,4-dibromothiazole (100 mg, 0.412 mmol) in 2 mL THF was added BuLi (1.6 M in THF, 283 μL, 0.453 mmol). The mixture was stirred at −78° C. for 15 min, then a solution of Intermediate 7.3 (134 mg, 0.412 mmol) in 0.6 mL THF was added dropwise. The mixture was stirred at −78° C. for 30 min, was allowed to warm to rt, then was quenched with sat. NH4Cl. The mixture was diluted with EtOAc, washed with H2O and brine, dried (Na2SO4) and concentrated. The crude product was purified by flash chromatography (0 to 40% EtOAc/hexanes gradient) followed by preparative HPLC purification to afford 39 mg of Intermediate 16.1.

Aufarbeitung

  1. stirringThe mixture was stirred at −78° C. for 30 min
  2. temperatureto warm to rt
  3. customwas quenched with sat. NH4Cl
  4. additionThe mixture was diluted with EtOAc
  5. washwashed with H2O and brine
  6. dry with materialdried (Na2SO4)
  7. concentrationconcentrated
  8. customThe crude product was purified by flash chromatography (0 to 40% EtOAc/hexanes gradient)
  9. customfollowed by preparative HPLC purification

Quellen und Nachweise

ORD-Eintrag
ord-09466bdbd88546ce8cb51f4629933834
Quelldatensatz
uspto-grants-2009_08
Patentnummer
US07576098B2

Notizen zur Reaktion

Wird geladen…